EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Anti-Diabetic Evaluation of 2-Phenyl-3H-quinazolin-4-one Derivatives

K P D H Pathirana, D A Upeka Chathurangani iD, Julian Vlad iD, D M W S Dissanayake, Yasiru Vindula Alwis, G Mashooda Jayah, K P S S Pathirana, Dinusha Nishani Udukala, Nishal M Egodawaththa iD, Jason P Farrah, Nasri Nesnas iD, Medha Jaimini Gunaratna iD

Pharmaceutics · 16.08.2026 · 18 (8) · 1013

DOI: 10.3390/pharmaceutics18081013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 16.08.2026. Verfasst von K P D H Pathirana und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical Sciences, Institute of Chemistry Ceylon, Rajagiriya, Sri Jayawardenepura Kotte 10107, Sri Lanka. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Diabetes mellitus is a common endocrine disorder characterized by hyperglycemia, which is increasing steadily all over the world. Current medications are limited due to lower efficacy and side effects; therefore, the introduction of novel compounds is crucial to improve therapeutic outcomes for diabetic patients. The objective of this study was to synthesize and evaluate 2-phenyl-3H-quinazolin-4-one and its derivatives for the glucose uptake across the yeast cell membranes, alpha-amylase inhibition, and alpha-glucosidase inhibition in silico and in vitro.

Methods

The synthesis of 2-phenyl-3H-quinazolin-4-one and its derivatives was carried out by oxidative cyclocondensation of 2-aminobenzamide (anthranilamide) with various benzaldehydes in the presence of aqueous iron (III) chloride. The synthesized compounds were characterized by melting point determination and spectroscopic techniques, including FTIR, NMR and HRMS.

Results

In the glucose uptake by yeast assay, compound 3f had a lower 50% glucose uptake value of 24.02 ± 0.96 mM, compared with the standard drug metformin (25.99 ± 2.41 mM). The alpha-amylase inhibition bioassay showed that compound 3e exhibited very potent inhibition, with an IC50 of 0.43 ± 0.05 mM, compared with the standard drug acarbose (0.53 ± 0.21 mM). Compound 3l exhibited strong alpha-glucosidase inhibition, with an IC50 of 0.42 ± 0.10 mM, compared with the standard drug acarbose (0.29 ± 0.50 mM). Coclusions: These findings suggest the potential of synthesized 2-phenyl-3H-quinazolin-4-one derivatives, 3a–o, as promising candidates for managing diabetes mellitus. However, further studies are required to validate their efficacy and determine their mechanisms of action.

Schlagwörter

Stichwörter der Autor:innen

2-Phenyl-3H-quinazolin-4-oneAntidiabetic activityQuinazolinone derivativeα-Amylase inhibitionα-Glucosidase inhibition

Autor:innen und Institutionen

  • College of Chemical Sciences, Institute of Chemistry Ceylon, Rajagiriya, Sri Jayawardenepura Kotte 10107, Sri Lanka.
  • Department of Chemistry and Chemical Engineering, Florida Institute of Technology, 150 West University Boulevard, Melbourne, FL 32901, USA.
  • Department of Chemistry, Faculty of Science, University of Kelaniya, Kelaniya 11600, Sri Lanka.
  • Body Revolution Aesthetics & Wellness, 1211 48th Avenue, Myrtle Beach, SC 29577, USA.

ORCID-Profile: D A Upeka Chathurangani, Julian Vlad, Nishal M Egodawaththa, Nasri Nesnas, Medha Jaimini Gunaratna

Zitieren

APA

Pathirana, K. P. D. H., Chathurangani, D. A. U., Vlad, J., Dissanayake, D. M. W. S., Alwis, Y. V., Jayah, G. M., Pathirana, K. P. S. S., Udukala, D. N., Egodawaththa, N. M., Farrah, J. P., Nesnas, N., & Gunaratna, M. J. (2026). Synthesis and Anti-Diabetic Evaluation of 2-Phenyl-3H-quinazolin-4-one Derivatives. Pharmaceutics, 18(8), 1013. https://doi.org/10.3390/pharmaceutics18081013

Vancouver

Pathirana KPDH, Chathurangani DAU, Vlad J, Dissanayake DMWS, Alwis YV, Jayah GM, et al. Synthesis and Anti-Diabetic Evaluation of 2-Phenyl-3H-quinazolin-4-one Derivatives. Pharmaceutics. 2026;18(8):1013. doi:10.3390/pharmaceutics18081013

BibTeX
@article{Pathirana2026,
  author = {Pathirana, K P D H and Chathurangani, D A Upeka and Vlad, Julian and Dissanayake, D M W S and Alwis, Yasiru Vindula and Jayah, G Mashooda and Pathirana, K P S S and Udukala, Dinusha Nishani and Egodawaththa, Nishal M and Farrah, Jason P and Nesnas, Nasri and Gunaratna, Medha Jaimini},
  title = {Synthesis and Anti-Diabetic Evaluation of 2-Phenyl-3H-quinazolin-4-one Derivatives},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {1013},
  doi = {10.3390/pharmaceutics18081013}
}
Kostenlos starten →